Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Amphastar Pharmaceuticals, Inc. (AMPH) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Amphastar Pharmaceuticals, Inc. (AMPH), most recent 12 months reported: revenue $730.02M, net income $78.55M, free cash flow $152.89M. Latest balance sheet on file: liquid cash $290.12M, total debt $612.05M, net cash -$321.93M. From SEC filings. Others in Pharmaceutical Preparations: AXSOME THERAPEUTICS, INC. · EMERGENT BIOSOLUTIONS INC. · Kiniksa Pharmaceuticals International, plc · PACIRA BIOSCIENCES, INC. · ULTRAGENYX PHARMACEUTICAL INC. · BridgeBio Pharma, Inc. · NURIX THERAPEUTICS, INC. · ARROWHEAD PHARMACEUTICALS, INC.

Stock screener

Watchlist